Abstract
We have identified GpsA, a predicted glycerol-3-phosphate dehydrogenase, as a virulence factor in the Lyme disease spirochete Borrelia (Borreliella) burgdorferi: GpsA is essential for murine infection and crucial for persistence of the spirochete in the tick. B. burgdorferi has a limited biosynthetic and metabolic capacity; the linchpin connecting central carbohydrate and lipid metabolism is at the interconversion of glycerol-3-phosphate and dihydroxyacetone phosphate, catalyzed by GpsA and another glycerol-3-phosphate dehydrogenase, GlpD. Using a broad metabolomics approach, we found that GpsA serves as a dominant regulator of NADH and glycerol-3-phosphate levels in vitro, metabolic intermediates that reflect the cellular redox potential and serve as a precursor for lipid and lipoprotein biosynthesis, respectively. Additionally, GpsA was required for survival under nutrient stress, regulated overall reductase activity and controlled B. burgdorferi morphology in vitro. Furthermore, during in vitro nutrient stress, both glycerol and N-acetylglucosamine were bactericidal to B. burgdorferi in a GlpD-dependent manner. This study is also the first to identify a suppressor mutation in B. burgdorferi: a glpD deletion restored the wild-type phenotype to the pleiotropic gpsA mutant, including murine infectivity by needle inoculation at high doses, survival under nutrient stress, morphological changes and the metabolic imbalance of NADH and glycerol-3-phosphate. These results illustrate how basic metabolic functions that are dispensable for in vitro growth can be essential for in vivo infectivity of B. burgdorferi and may serve as attractive therapeutic targets.
| Original language | English |
|---|---|
| Article number | e1010385 |
| Journal | PLoS Pathogens |
| Volume | 18 |
| Issue number | 3 |
| DOIs | |
| State | Published - Mar 2022 |
Funding
This work was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health (R01AI130247 to DSS, DD and MCL) and provided by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases of the National Institutes of Health (CMB and FG). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. We are grateful to the LAR staff for animal care in all mouse experiments. We thank Tom Schwan for anti-FlaB antibodies and Pat Secor for the pUC18 expression vector and use of the plate reader for luminescence experiments. We also thank Steve Lodmell for critical review of the manuscript.
| Funder number |
|---|
| ZIAAI001013, R01AI130247 |